Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Angiotensin 1-7 blunts in vitro induced acute heart failure

Show simple item record

dc.contributor.author Cobet, V.
dc.contributor.author Tacu, L.
dc.contributor.author Cobet, E.
dc.contributor.author Rotaru, V.
dc.contributor.author Ciobanu, L.
dc.contributor.author Rotaru, A.
dc.date.accessioned 2022-01-26T15:00:59Z
dc.date.available 2022-01-26T15:00:59Z
dc.date.issued 2017
dc.identifier.issn 1879-0844
dc.identifier.uri https://onlinelibrary.wiley.com/doi/epdf/10.1002/ejhf.833
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/19699
dc.description.abstract Background: Angiotensin 1-7 (Ang 1-7) comprises consistent evidences regarding cardiovascular regulatory benefits due to Ang II receptor AT1 modulation via mass receptor.Aim: Evaluation of the Ang 1-7 cardiac effects in the in vitro induced acute heart failure.Material and methods: Acute heart failure (AHF) was induced using the model of isolated rat pumping heart perfused by Krebs solution without glucose during20 min according to Neely-Rovetto model (glucose is a single energetic substrate in this model) – control series. In another series heart has been perfused without glucose, but Ang 1-7 was added till final concentration of 10-7 M – medicated series. Left ventricle (LV) functional parameters were assayed during inotropic stimulation by norepinephrine (NE) and endothelin 1 (ET-1) in concentration of 10-6M, or ischemia-reperfusion impact (15 min of total ischemia followed by 20 min of reperfusion) reproduced in Langendorff isovolumic isolated heart. Results: Cardiac output (CO) significantly decreased after 20 min perfusion of isolate heart without glucose by 25,9% (29,4±1,3 vs 39,7±2,1 ml/min). Action of Ang 1-7led to a less decline of CO compared to control (34,8±1,6 vs 29,4±1,3 ml/min,p<0,05). NE stimulation induced an increase of control CO by 10,7% associated by LV end-diastolic pressure (LVEDP) elevation of 30,3% while in medicated series response was better: CO increased by 14,4% and LVEDP boosted only by 17,6%((19,3±1,6 (Ang 1-7) vs 27,4±1,7 (control) mm Hg, p<0,05). Stimulated by ET-1control isolated heart responded by a negative inotropic effect, and both systolicLV pressure and CO fallen respectively by 13,2% and 9,6%. Ang 1-7 insured a positive inotropic response during ET-1 action leading to CO and LV systolic pressure increase respectively by 10,5% and 11,7%. Ang 1-7 also improved the dynamics of LVEDP during ischemia-reperfusion. Thus, LVEDP was in medicated series significantly less than control index at finish of both ischemia (41,3±3,2 vs55,4±4,4 mm Hg) and reperfusion (17,2±1,4 vs 28,7±2,2 mm Hg) periods. Conclusion: Angiotensin 1-7 is a component of renin-angiotensin-aldosterone system which has a benefic action on acutely developing heart failure due to energy privation, manifested by improvement of the inotropic response of NE and reinstate positive inotropic of ET-1 action as well as significant diminution of LVEDP during ischemia-reperfusion syndrome. en_US
dc.language.iso en en_US
dc.publisher European Society of Cardiology en_US
dc.relation.ispartof European Journal of Heart Failure: Special Issue: Abstracts of the Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, Paris, France, 29 April – 2 May 2017 en_US
dc.title Angiotensin 1-7 blunts in vitro induced acute heart failure en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics